Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant

NCT00005852 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

OTHER

Sponsor class

Stopped low accrual

Conditions

Chronic Myeloproliferative Disorders
Graft Versus Host Disease
Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
BIOLOGICAL: muromonab-CD3
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: methylprednisolone
PROCEDURE: allogeneic bone marrow transplantation

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]